nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP2D6—Carteolol—glaucoma	0.086	0.154	CbGbCtD
Temsirolimus—CYP2D6—Betaxolol—glaucoma	0.0581	0.104	CbGbCtD
Temsirolimus—CYP3A5—Clonidine—glaucoma	0.0519	0.0929	CbGbCtD
Temsirolimus—CYP2D6—Methazolamide—glaucoma	0.044	0.0788	CbGbCtD
Temsirolimus—CYP3A4—Pilocarpine—glaucoma	0.0414	0.0742	CbGbCtD
Temsirolimus—ABCB1—Timolol—glaucoma	0.0397	0.0711	CbGbCtD
Temsirolimus—CYP2D6—Timolol—glaucoma	0.0374	0.067	CbGbCtD
Temsirolimus—ABCB1—Clonidine—glaucoma	0.0338	0.0604	CbGbCtD
Temsirolimus—CYP3A4—Brinzolamide—glaucoma	0.0325	0.0582	CbGbCtD
Temsirolimus—CYP2D6—Clonidine—glaucoma	0.0318	0.057	CbGbCtD
Temsirolimus—CYP3A4—Dorzolamide—glaucoma	0.0314	0.0562	CbGbCtD
Temsirolimus—CYP3A4—Methazolamide—glaucoma	0.028	0.0501	CbGbCtD
Temsirolimus—CYP3A4—Acetazolamide—glaucoma	0.0224	0.04	CbGbCtD
Temsirolimus—CYP3A4—Clonidine—glaucoma	0.0202	0.0362	CbGbCtD
Temsirolimus—Nausea—Methazolamide—glaucoma	0.000317	0.000973	CcSEcCtD
Temsirolimus—Dyspnoea—Brimonidine—glaucoma	0.000317	0.00097	CcSEcCtD
Temsirolimus—Somnolence—Brimonidine—glaucoma	0.000316	0.000968	CcSEcCtD
Temsirolimus—Mental disorder—Clonidine—glaucoma	0.000316	0.000967	CcSEcCtD
Temsirolimus—Rhinitis—Betaxolol—glaucoma	0.000314	0.000964	CcSEcCtD
Temsirolimus—Thrombocytopenia—Pilocarpine—glaucoma	0.000314	0.000962	CcSEcCtD
Temsirolimus—Erythema—Clonidine—glaucoma	0.000314	0.000961	CcSEcCtD
Temsirolimus—Pharyngitis—Betaxolol—glaucoma	0.000311	0.000954	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000309	0.000947	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Travoprost—glaucoma	0.000308	0.000943	CcSEcCtD
Temsirolimus—Insomnia—Dorzolamide—glaucoma	0.000307	0.00094	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Brimonidine—glaucoma	0.000307	0.00094	CcSEcCtD
Temsirolimus—Fatigue—Brimonidine—glaucoma	0.000306	0.000938	CcSEcCtD
Temsirolimus—Anorexia—Pilocarpine—glaucoma	0.000305	0.000936	CcSEcCtD
Temsirolimus—Hypersensitivity—Apraclonidine—glaucoma	0.000305	0.000934	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000304	0.000931	CcSEcCtD
Temsirolimus—Pain—Brimonidine—glaucoma	0.000304	0.000931	CcSEcCtD
Temsirolimus—Dyspnoea—Dorzolamide—glaucoma	0.000302	0.000927	CcSEcCtD
Temsirolimus—Insomnia—Brinzolamide—glaucoma	0.000302	0.000924	CcSEcCtD
Temsirolimus—Somnolence—Dorzolamide—glaucoma	0.000301	0.000924	CcSEcCtD
Temsirolimus—Dyspnoea—Travoprost—glaucoma	0.000301	0.000923	CcSEcCtD
Temsirolimus—Dysuria—Timolol—glaucoma	0.000299	0.000917	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Timolol—glaucoma	0.000297	0.000912	CcSEcCtD
Temsirolimus—Dyspnoea—Brinzolamide—glaucoma	0.000297	0.000911	CcSEcCtD
Temsirolimus—Asthenia—Apraclonidine—glaucoma	0.000297	0.00091	CcSEcCtD
Temsirolimus—Somnolence—Brinzolamide—glaucoma	0.000296	0.000908	CcSEcCtD
Temsirolimus—Decreased appetite—Dorzolamide—glaucoma	0.000295	0.000903	CcSEcCtD
Temsirolimus—Eye disorder—Betaxolol—glaucoma	0.000293	0.000898	CcSEcCtD
Temsirolimus—Pruritus—Apraclonidine—glaucoma	0.000293	0.000897	CcSEcCtD
Temsirolimus—Body temperature increased—Acetazolamide—glaucoma	0.000292	0.000896	CcSEcCtD
Temsirolimus—Fatigue—Dorzolamide—glaucoma	0.000292	0.000896	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000292	0.000895	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Travoprost—glaucoma	0.000292	0.000893	CcSEcCtD
Temsirolimus—Fatigue—Travoprost—glaucoma	0.000291	0.000892	CcSEcCtD
Temsirolimus—Cardiac disorder—Betaxolol—glaucoma	0.000291	0.000892	CcSEcCtD
Temsirolimus—Pain—Dorzolamide—glaucoma	0.00029	0.000889	CcSEcCtD
Temsirolimus—Insomnia—Pilocarpine—glaucoma	0.00029	0.000888	CcSEcCtD
Temsirolimus—Decreased appetite—Brinzolamide—glaucoma	0.00029	0.000888	CcSEcCtD
Temsirolimus—Weight decreased—Timolol—glaucoma	0.00029	0.000887	CcSEcCtD
Temsirolimus—Constipation—Travoprost—glaucoma	0.000289	0.000885	CcSEcCtD
Temsirolimus—Pain—Travoprost—glaucoma	0.000289	0.000885	CcSEcCtD
Temsirolimus—Hyperglycaemia—Timolol—glaucoma	0.000289	0.000885	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000288	0.000882	CcSEcCtD
Temsirolimus—Asthenia—Bimatoprost—glaucoma	0.000288	0.000882	CcSEcCtD
Temsirolimus—Fatigue—Brinzolamide—glaucoma	0.000287	0.000881	CcSEcCtD
Temsirolimus—Angioedema—Clonidine—glaucoma	0.000286	0.000878	CcSEcCtD
Temsirolimus—Dyspnoea—Pilocarpine—glaucoma	0.000286	0.000876	CcSEcCtD
Temsirolimus—Pain—Brinzolamide—glaucoma	0.000285	0.000874	CcSEcCtD
Temsirolimus—Somnolence—Pilocarpine—glaucoma	0.000285	0.000873	CcSEcCtD
Temsirolimus—Depression—Timolol—glaucoma	0.000285	0.000872	CcSEcCtD
Temsirolimus—Angiopathy—Betaxolol—glaucoma	0.000284	0.000872	CcSEcCtD
Temsirolimus—Pruritus—Bimatoprost—glaucoma	0.000284	0.00087	CcSEcCtD
Temsirolimus—Immune system disorder—Betaxolol—glaucoma	0.000283	0.000868	CcSEcCtD
Temsirolimus—Diarrhoea—Apraclonidine—glaucoma	0.000283	0.000867	CcSEcCtD
Temsirolimus—Mediastinal disorder—Betaxolol—glaucoma	0.000283	0.000866	CcSEcCtD
Temsirolimus—Chills—Betaxolol—glaucoma	0.000281	0.000862	CcSEcCtD
Temsirolimus—Decreased appetite—Pilocarpine—glaucoma	0.000279	0.000854	CcSEcCtD
Temsirolimus—Conjunctivitis—Timolol—glaucoma	0.000277	0.00085	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Dorzolamide—glaucoma	0.000277	0.00085	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000277	0.000848	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Travoprost—glaucoma	0.000276	0.000846	CcSEcCtD
Temsirolimus—Mental disorder—Betaxolol—glaucoma	0.000275	0.000842	CcSEcCtD
Temsirolimus—Pain—Pilocarpine—glaucoma	0.000274	0.00084	CcSEcCtD
Temsirolimus—Constipation—Pilocarpine—glaucoma	0.000274	0.00084	CcSEcCtD
Temsirolimus—Cough—Clonidine—glaucoma	0.000274	0.000839	CcSEcCtD
Temsirolimus—Dizziness—Apraclonidine—glaucoma	0.000274	0.000838	CcSEcCtD
Temsirolimus—Malnutrition—Betaxolol—glaucoma	0.000273	0.000837	CcSEcCtD
Temsirolimus—Erythema—Betaxolol—glaucoma	0.000273	0.000837	CcSEcCtD
Temsirolimus—Epistaxis—Timolol—glaucoma	0.000269	0.000825	CcSEcCtD
Temsirolimus—Abdominal pain—Dorzolamide—glaucoma	0.000268	0.000822	CcSEcCtD
Temsirolimus—Body temperature increased—Dorzolamide—glaucoma	0.000268	0.000822	CcSEcCtD
Temsirolimus—Sinusitis—Timolol—glaucoma	0.000268	0.000821	CcSEcCtD
Temsirolimus—Dysgeusia—Betaxolol—glaucoma	0.000267	0.000819	CcSEcCtD
Temsirolimus—Chest pain—Clonidine—glaucoma	0.000267	0.000818	CcSEcCtD
Temsirolimus—Arthralgia—Clonidine—glaucoma	0.000267	0.000818	CcSEcCtD
Temsirolimus—Abdominal pain—Travoprost—glaucoma	0.000267	0.000818	CcSEcCtD
Temsirolimus—Anxiety—Clonidine—glaucoma	0.000266	0.000815	CcSEcCtD
Temsirolimus—Asthenia—Acetazolamide—glaucoma	0.000265	0.000814	CcSEcCtD
Temsirolimus—Dizziness—Bimatoprost—glaucoma	0.000265	0.000813	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000265	0.000812	CcSEcCtD
Temsirolimus—Vomiting—Apraclonidine—glaucoma	0.000263	0.000806	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Pilocarpine—glaucoma	0.000262	0.000803	CcSEcCtD
Temsirolimus—Hypersensitivity—Brimonidine—glaucoma	0.000262	0.000802	CcSEcCtD
Temsirolimus—Dermatitis—Apraclonidine—glaucoma	0.000261	0.000799	CcSEcCtD
Temsirolimus—Headache—Apraclonidine—glaucoma	0.000259	0.000794	CcSEcCtD
Temsirolimus—Rhinitis—Timolol—glaucoma	0.000257	0.000787	CcSEcCtD
Temsirolimus—Oedema—Clonidine—glaucoma	0.000256	0.000784	CcSEcCtD
Temsirolimus—Asthenia—Brimonidine—glaucoma	0.000255	0.000781	CcSEcCtD
Temsirolimus—Infection—Clonidine—glaucoma	0.000254	0.000779	CcSEcCtD
Temsirolimus—Abdominal pain—Pilocarpine—glaucoma	0.000253	0.000776	CcSEcCtD
Temsirolimus—Body temperature increased—Pilocarpine—glaucoma	0.000253	0.000776	CcSEcCtD
Temsirolimus—Diarrhoea—Acetazolamide—glaucoma	0.000253	0.000776	CcSEcCtD
Temsirolimus—Rash—Bimatoprost—glaucoma	0.000253	0.000775	CcSEcCtD
Temsirolimus—Dermatitis—Bimatoprost—glaucoma	0.000253	0.000774	CcSEcCtD
Temsirolimus—Oedema peripheral—Timolol—glaucoma	0.000252	0.000773	CcSEcCtD
Temsirolimus—Anaemia—Betaxolol—glaucoma	0.000252	0.000773	CcSEcCtD
Temsirolimus—Connective tissue disorder—Timolol—glaucoma	0.000252	0.000772	CcSEcCtD
Temsirolimus—Pruritus—Brimonidine—glaucoma	0.000251	0.00077	CcSEcCtD
Temsirolimus—Headache—Bimatoprost—glaucoma	0.000251	0.00077	CcSEcCtD
Temsirolimus—Nervous system disorder—Clonidine—glaucoma	0.000251	0.000769	CcSEcCtD
Temsirolimus—Thrombocytopenia—Clonidine—glaucoma	0.000251	0.000768	CcSEcCtD
Temsirolimus—Hypersensitivity—Dorzolamide—glaucoma	0.00025	0.000766	CcSEcCtD
Temsirolimus—Hypersensitivity—Travoprost—glaucoma	0.000249	0.000762	CcSEcCtD
Temsirolimus—Skin disorder—Clonidine—glaucoma	0.000249	0.000762	CcSEcCtD
Temsirolimus—Nausea—Apraclonidine—glaucoma	0.000246	0.000753	CcSEcCtD
Temsirolimus—Hypersensitivity—Brinzolamide—glaucoma	0.000246	0.000753	CcSEcCtD
Temsirolimus—Dizziness—Acetazolamide—glaucoma	0.000245	0.00075	CcSEcCtD
Temsirolimus—Anorexia—Clonidine—glaucoma	0.000244	0.000748	CcSEcCtD
Temsirolimus—Asthenia—Dorzolamide—glaucoma	0.000243	0.000746	CcSEcCtD
Temsirolimus—Asthenia—Travoprost—glaucoma	0.000242	0.000742	CcSEcCtD
Temsirolimus—Pruritus—Dorzolamide—glaucoma	0.00024	0.000735	CcSEcCtD
Temsirolimus—Eye disorder—Timolol—glaucoma	0.000239	0.000734	CcSEcCtD
Temsirolimus—Asthenia—Brinzolamide—glaucoma	0.000239	0.000733	CcSEcCtD
Temsirolimus—Pruritus—Travoprost—glaucoma	0.000239	0.000732	CcSEcCtD
Temsirolimus—Cough—Betaxolol—glaucoma	0.000238	0.00073	CcSEcCtD
Temsirolimus—Nausea—Bimatoprost—glaucoma	0.000238	0.00073	CcSEcCtD
Temsirolimus—Cardiac disorder—Timolol—glaucoma	0.000238	0.000729	CcSEcCtD
Temsirolimus—Hypersensitivity—Pilocarpine—glaucoma	0.000236	0.000724	CcSEcCtD
Temsirolimus—Pruritus—Brinzolamide—glaucoma	0.000236	0.000723	CcSEcCtD
Temsirolimus—Vomiting—Acetazolamide—glaucoma	0.000235	0.000721	CcSEcCtD
Temsirolimus—Dizziness—Brimonidine—glaucoma	0.000235	0.00072	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Clonidine—glaucoma	0.000233	0.000715	CcSEcCtD
Temsirolimus—Angiopathy—Timolol—glaucoma	0.000232	0.000712	CcSEcCtD
Temsirolimus—Arthralgia—Betaxolol—glaucoma	0.000232	0.000712	CcSEcCtD
Temsirolimus—Myalgia—Betaxolol—glaucoma	0.000232	0.000712	CcSEcCtD
Temsirolimus—Chest pain—Betaxolol—glaucoma	0.000232	0.000712	CcSEcCtD
Temsirolimus—Diarrhoea—Dorzolamide—glaucoma	0.000232	0.000711	CcSEcCtD
Temsirolimus—Headache—Acetazolamide—glaucoma	0.000232	0.00071	CcSEcCtD
Temsirolimus—Anxiety—Betaxolol—glaucoma	0.000232	0.00071	CcSEcCtD
Temsirolimus—Insomnia—Clonidine—glaucoma	0.000231	0.000709	CcSEcCtD
Temsirolimus—Immune system disorder—Timolol—glaucoma	0.000231	0.000709	CcSEcCtD
Temsirolimus—Diarrhoea—Travoprost—glaucoma	0.000231	0.000708	CcSEcCtD
Temsirolimus—Mediastinal disorder—Timolol—glaucoma	0.000231	0.000708	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000231	0.000707	CcSEcCtD
Temsirolimus—Asthenia—Pilocarpine—glaucoma	0.00023	0.000705	CcSEcCtD
Temsirolimus—Dyspnoea—Clonidine—glaucoma	0.000228	0.000699	CcSEcCtD
Temsirolimus—Diarrhoea—Brinzolamide—glaucoma	0.000228	0.000699	CcSEcCtD
Temsirolimus—Somnolence—Clonidine—glaucoma	0.000227	0.000697	CcSEcCtD
Temsirolimus—Pruritus—Pilocarpine—glaucoma	0.000227	0.000695	CcSEcCtD
Temsirolimus—Mental disorder—Timolol—glaucoma	0.000224	0.000688	CcSEcCtD
Temsirolimus—Dizziness—Dorzolamide—glaucoma	0.000224	0.000687	CcSEcCtD
Temsirolimus—Rash—Brimonidine—glaucoma	0.000224	0.000686	CcSEcCtD
Temsirolimus—Dermatitis—Brimonidine—glaucoma	0.000224	0.000686	CcSEcCtD
Temsirolimus—Dizziness—Travoprost—glaucoma	0.000223	0.000684	CcSEcCtD
Temsirolimus—Erythema—Timolol—glaucoma	0.000223	0.000683	CcSEcCtD
Temsirolimus—Malnutrition—Timolol—glaucoma	0.000223	0.000683	CcSEcCtD
Temsirolimus—Oedema—Betaxolol—glaucoma	0.000223	0.000683	CcSEcCtD
Temsirolimus—Headache—Brimonidine—glaucoma	0.000222	0.000682	CcSEcCtD
Temsirolimus—Decreased appetite—Clonidine—glaucoma	0.000222	0.000682	CcSEcCtD
Temsirolimus—Infection—Betaxolol—glaucoma	0.000221	0.000678	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Clonidine—glaucoma	0.000221	0.000677	CcSEcCtD
Temsirolimus—Fatigue—Clonidine—glaucoma	0.000221	0.000676	CcSEcCtD
Temsirolimus—Dizziness—Brinzolamide—glaucoma	0.00022	0.000676	CcSEcCtD
Temsirolimus—Nausea—Acetazolamide—glaucoma	0.00022	0.000674	CcSEcCtD
Temsirolimus—Diarrhoea—Pilocarpine—glaucoma	0.000219	0.000672	CcSEcCtD
Temsirolimus—Pain—Clonidine—glaucoma	0.000219	0.000671	CcSEcCtD
Temsirolimus—Constipation—Clonidine—glaucoma	0.000219	0.000671	CcSEcCtD
Temsirolimus—Nervous system disorder—Betaxolol—glaucoma	0.000218	0.00067	CcSEcCtD
Temsirolimus—Dysgeusia—Timolol—glaucoma	0.000218	0.000669	CcSEcCtD
Temsirolimus—Thrombocytopenia—Betaxolol—glaucoma	0.000218	0.000669	CcSEcCtD
Temsirolimus—Skin disorder—Betaxolol—glaucoma	0.000216	0.000663	CcSEcCtD
Temsirolimus—Vomiting—Dorzolamide—glaucoma	0.000216	0.000661	CcSEcCtD
Temsirolimus—Rash—Dorzolamide—glaucoma	0.000214	0.000655	CcSEcCtD
Temsirolimus—Dermatitis—Dorzolamide—glaucoma	0.000214	0.000655	CcSEcCtD
Temsirolimus—Rash—Travoprost—glaucoma	0.000213	0.000652	CcSEcCtD
Temsirolimus—Dermatitis—Travoprost—glaucoma	0.000213	0.000652	CcSEcCtD
Temsirolimus—Headache—Dorzolamide—glaucoma	0.000212	0.000651	CcSEcCtD
Temsirolimus—Anorexia—Betaxolol—glaucoma	0.000212	0.000651	CcSEcCtD
Temsirolimus—Vomiting—Brinzolamide—glaucoma	0.000212	0.00065	CcSEcCtD
Temsirolimus—Dizziness—Pilocarpine—glaucoma	0.000212	0.000649	CcSEcCtD
Temsirolimus—Headache—Travoprost—glaucoma	0.000212	0.000648	CcSEcCtD
Temsirolimus—Nausea—Brimonidine—glaucoma	0.000211	0.000646	CcSEcCtD
Temsirolimus—Rash—Brinzolamide—glaucoma	0.00021	0.000644	CcSEcCtD
Temsirolimus—Dermatitis—Brinzolamide—glaucoma	0.00021	0.000644	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Clonidine—glaucoma	0.000209	0.000641	CcSEcCtD
Temsirolimus—Headache—Brinzolamide—glaucoma	0.000209	0.00064	CcSEcCtD
Temsirolimus—Angioedema—Timolol—glaucoma	0.000204	0.000625	CcSEcCtD
Temsirolimus—Vomiting—Pilocarpine—glaucoma	0.000204	0.000624	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000203	0.000622	CcSEcCtD
Temsirolimus—Abdominal pain—Clonidine—glaucoma	0.000202	0.00062	CcSEcCtD
Temsirolimus—Body temperature increased—Clonidine—glaucoma	0.000202	0.00062	CcSEcCtD
Temsirolimus—Rash—Pilocarpine—glaucoma	0.000202	0.000619	CcSEcCtD
Temsirolimus—Dermatitis—Pilocarpine—glaucoma	0.000202	0.000619	CcSEcCtD
Temsirolimus—Insomnia—Betaxolol—glaucoma	0.000201	0.000618	CcSEcCtD
Temsirolimus—Nausea—Dorzolamide—glaucoma	0.000201	0.000617	CcSEcCtD
Temsirolimus—Headache—Pilocarpine—glaucoma	0.000201	0.000615	CcSEcCtD
Temsirolimus—Nausea—Travoprost—glaucoma	0.000201	0.000615	CcSEcCtD
Temsirolimus—Dyspnoea—Betaxolol—glaucoma	0.000199	0.000609	CcSEcCtD
Temsirolimus—Nausea—Brinzolamide—glaucoma	0.000198	0.000607	CcSEcCtD
Temsirolimus—Cough—Timolol—glaucoma	0.000195	0.000596	CcSEcCtD
Temsirolimus—Decreased appetite—Betaxolol—glaucoma	0.000194	0.000594	CcSEcCtD
Temsirolimus—Hypertension—Timolol—glaucoma	0.000193	0.00059	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Betaxolol—glaucoma	0.000192	0.000589	CcSEcCtD
Temsirolimus—Fatigue—Betaxolol—glaucoma	0.000192	0.000589	CcSEcCtD
Temsirolimus—Pain—Betaxolol—glaucoma	0.000191	0.000584	CcSEcCtD
Temsirolimus—Constipation—Betaxolol—glaucoma	0.000191	0.000584	CcSEcCtD
Temsirolimus—Nausea—Pilocarpine—glaucoma	0.00019	0.000583	CcSEcCtD
Temsirolimus—Arthralgia—Timolol—glaucoma	0.00019	0.000582	CcSEcCtD
Temsirolimus—Chest pain—Timolol—glaucoma	0.00019	0.000582	CcSEcCtD
Temsirolimus—Myalgia—Timolol—glaucoma	0.00019	0.000582	CcSEcCtD
Temsirolimus—Anxiety—Timolol—glaucoma	0.000189	0.00058	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000189	0.000578	CcSEcCtD
Temsirolimus—Hypersensitivity—Clonidine—glaucoma	0.000189	0.000578	CcSEcCtD
Temsirolimus—Asthenia—Clonidine—glaucoma	0.000184	0.000563	CcSEcCtD
Temsirolimus—Oedema—Timolol—glaucoma	0.000182	0.000558	CcSEcCtD
Temsirolimus—Anaphylactic shock—Timolol—glaucoma	0.000182	0.000558	CcSEcCtD
Temsirolimus—Pruritus—Clonidine—glaucoma	0.000181	0.000555	CcSEcCtD
Temsirolimus—Infection—Timolol—glaucoma	0.000181	0.000554	CcSEcCtD
Temsirolimus—Nervous system disorder—Timolol—glaucoma	0.000178	0.000547	CcSEcCtD
Temsirolimus—Skin disorder—Timolol—glaucoma	0.000177	0.000542	CcSEcCtD
Temsirolimus—Body temperature increased—Betaxolol—glaucoma	0.000176	0.00054	CcSEcCtD
Temsirolimus—Diarrhoea—Clonidine—glaucoma	0.000175	0.000537	CcSEcCtD
Temsirolimus—Anorexia—Timolol—glaucoma	0.000173	0.000532	CcSEcCtD
Temsirolimus—Dizziness—Clonidine—glaucoma	0.000169	0.000519	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Timolol—glaucoma	0.000166	0.000508	CcSEcCtD
Temsirolimus—Insomnia—Timolol—glaucoma	0.000165	0.000505	CcSEcCtD
Temsirolimus—Hypersensitivity—Betaxolol—glaucoma	0.000164	0.000503	CcSEcCtD
Temsirolimus—Vomiting—Clonidine—glaucoma	0.000163	0.000499	CcSEcCtD
Temsirolimus—Dyspnoea—Timolol—glaucoma	0.000162	0.000497	CcSEcCtD
Temsirolimus—Somnolence—Timolol—glaucoma	0.000162	0.000496	CcSEcCtD
Temsirolimus—Rash—Clonidine—glaucoma	0.000161	0.000494	CcSEcCtD
Temsirolimus—Dermatitis—Clonidine—glaucoma	0.000161	0.000494	CcSEcCtD
Temsirolimus—Headache—Clonidine—glaucoma	0.00016	0.000491	CcSEcCtD
Temsirolimus—Asthenia—Betaxolol—glaucoma	0.00016	0.00049	CcSEcCtD
Temsirolimus—Decreased appetite—Timolol—glaucoma	0.000158	0.000485	CcSEcCtD
Temsirolimus—Pruritus—Betaxolol—glaucoma	0.000158	0.000483	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Timolol—glaucoma	0.000157	0.000482	CcSEcCtD
Temsirolimus—Fatigue—Timolol—glaucoma	0.000157	0.000481	CcSEcCtD
Temsirolimus—Pain—Timolol—glaucoma	0.000156	0.000477	CcSEcCtD
Temsirolimus—MTOR—Signaling by NGF—NGFR—glaucoma	0.000153	0.00133	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—BAD—glaucoma	0.000153	0.00133	CbGpPWpGaD
Temsirolimus—Diarrhoea—Betaxolol—glaucoma	0.000152	0.000467	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—HEYL—glaucoma	0.000152	0.00132	CbGpPWpGaD
Temsirolimus—Nausea—Clonidine—glaucoma	0.000152	0.000466	CcSEcCtD
Temsirolimus—MTOR—DAP12 signaling—BAD—glaucoma	0.000152	0.00132	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—CDKN1B—glaucoma	0.000151	0.00131	CbGpPWpGaD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—CDKN1B—glaucoma	0.000151	0.00131	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—SOD1—glaucoma	0.000151	0.00131	CbGpPWpGaD
Temsirolimus—CYP3A7—Biological oxidations—GSTM1—glaucoma	0.00015	0.00131	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—BAD—glaucoma	0.00015	0.0013	CbGpPWpGaD
Temsirolimus—Gastrointestinal pain—Timolol—glaucoma	0.000149	0.000456	CcSEcCtD
Temsirolimus—CYP3A7—Metapathway biotransformation—GSTM1—glaucoma	0.000148	0.00129	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PTGFR—glaucoma	0.000147	0.00128	CbGpPWpGaD
Temsirolimus—Dizziness—Betaxolol—glaucoma	0.000147	0.000452	CcSEcCtD
Temsirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000147	0.00128	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TXN—glaucoma	0.000147	0.00127	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—NTRK1—glaucoma	0.000145	0.00126	CbGpPWpGaD
Temsirolimus—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000145	0.00126	CbGpPWpGaD
Temsirolimus—Body temperature increased—Timolol—glaucoma	0.000144	0.000441	CcSEcCtD
Temsirolimus—Abdominal pain—Timolol—glaucoma	0.000144	0.000441	CcSEcCtD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—BAD—glaucoma	0.000143	0.00124	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—BAD—glaucoma	0.000143	0.00124	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—BAD—glaucoma	0.000143	0.00124	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDKN2B—glaucoma	0.000143	0.00124	CbGpPWpGaD
Temsirolimus—Vomiting—Betaxolol—glaucoma	0.000142	0.000434	CcSEcCtD
Temsirolimus—MTOR—Signaling by EGFR—BAD—glaucoma	0.000142	0.00123	CbGpPWpGaD
Temsirolimus—Rash—Betaxolol—glaucoma	0.00014	0.000431	CcSEcCtD
Temsirolimus—Dermatitis—Betaxolol—glaucoma	0.00014	0.00043	CcSEcCtD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—BAD—glaucoma	0.00014	0.00122	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—BAD—glaucoma	0.00014	0.00121	CbGpPWpGaD
Temsirolimus—Headache—Betaxolol—glaucoma	0.00014	0.000428	CcSEcCtD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—TP53—glaucoma	0.000139	0.00121	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000138	0.0012	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—FAS—glaucoma	0.000137	0.00119	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL1A—glaucoma	0.000136	0.00118	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—CYP1B1—glaucoma	0.000136	0.00118	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HDAC9—glaucoma	0.000136	0.00118	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—C3—glaucoma	0.000135	0.00117	CbGpPWpGaD
Temsirolimus—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	0.000134	0.00117	CbGpPWpGaD
Temsirolimus—Hypersensitivity—Timolol—glaucoma	0.000134	0.000411	CcSEcCtD
Temsirolimus—MTOR—Signaling Pathways—LRP12—glaucoma	0.000133	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—AMPK Signaling—TP53—glaucoma	0.000133	0.00115	CbGpPWpGaD
Temsirolimus—Nausea—Betaxolol—glaucoma	0.000132	0.000406	CcSEcCtD
Temsirolimus—MTOR—B Cell Activation—BAD—glaucoma	0.000132	0.00115	CbGpPWpGaD
Temsirolimus—Asthenia—Timolol—glaucoma	0.000131	0.0004	CcSEcCtD
Temsirolimus—Pruritus—Timolol—glaucoma	0.000129	0.000395	CcSEcCtD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—glaucoma	0.000129	0.00112	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTSA—glaucoma	0.000128	0.00111	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	0.000126	0.0011	CbGpPWpGaD
Temsirolimus—Diarrhoea—Timolol—glaucoma	0.000125	0.000382	CcSEcCtD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—VEGFA—glaucoma	0.000124	0.00108	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—NOS3—glaucoma	0.000123	0.00107	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FGFR1OP—glaucoma	0.000122	0.00106	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HEYL—glaucoma	0.000122	0.00106	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—GSTT1—glaucoma	0.000121	0.00105	CbGpPWpGaD
Temsirolimus—Dizziness—Timolol—glaucoma	0.00012	0.000369	CcSEcCtD
Temsirolimus—CYP3A5—Metabolism—CA5A—glaucoma	0.00012	0.00104	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NARFL—glaucoma	0.00012	0.00104	CbGpPWpGaD
Temsirolimus—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.00012	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—CDKN1B—glaucoma	0.000119	0.00104	CbGpPWpGaD
Temsirolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000119	0.00103	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000119	0.00103	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—NGF—glaucoma	0.000118	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—VEGFA—glaucoma	0.000117	0.00101	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000116	0.00101	CbGpPWpGaD
Temsirolimus—Vomiting—Timolol—glaucoma	0.000116	0.000355	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—RPTOR—glaucoma	0.000115	0.001	CbGpPWpGaD
Temsirolimus—Rash—Timolol—glaucoma	0.000115	0.000352	CcSEcCtD
Temsirolimus—Dermatitis—Timolol—glaucoma	0.000115	0.000351	CcSEcCtD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—CDKN1B—glaucoma	0.000114	0.000992	CbGpPWpGaD
Temsirolimus—Headache—Timolol—glaucoma	0.000114	0.000349	CcSEcCtD
Temsirolimus—MTOR—Signaling by ERBB4—CDKN1B—glaucoma	0.000112	0.000976	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NCK2—glaucoma	0.000112	0.000971	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000111	0.000962	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—MMP9—glaucoma	0.00011	0.00096	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—GSTM1—glaucoma	0.000109	0.000945	CbGpPWpGaD
Temsirolimus—Nausea—Timolol—glaucoma	0.000108	0.000331	CcSEcCtD
Temsirolimus—MTOR—Immune System—TXNIP—glaucoma	0.000108	0.000938	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—CDKN1B—glaucoma	0.000107	0.000932	CbGpPWpGaD
Temsirolimus—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	0.000107	0.000932	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—CDKN1B—glaucoma	0.000107	0.000928	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—CDKN1B—glaucoma	0.000106	0.000923	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TBK1—glaucoma	0.000106	0.00092	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—CDKN1B—glaucoma	0.000106	0.000919	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000105	0.000909	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—glaucoma	0.000104	0.000905	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—CDKN1B—glaucoma	9.94e-05	0.000864	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	9.94e-05	0.000864	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—CDKN1B—glaucoma	9.94e-05	0.000864	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—CDKN1B—glaucoma	9.86e-05	0.000856	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—CDKN1B—glaucoma	9.77e-05	0.000849	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—BAD—glaucoma	9.73e-05	0.000845	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—CDKN1B—glaucoma	9.73e-05	0.000845	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—CYP1B1—glaucoma	9.67e-05	0.00084	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—C1QB—glaucoma	9.57e-05	0.000832	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	9.54e-05	0.000829	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HDAC9—glaucoma	9.5e-05	0.000826	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TP53—glaucoma	9.49e-05	0.000825	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	9.39e-05	0.000816	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—OPN4—glaucoma	9.21e-05	0.0008	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—CDKN1B—glaucoma	9.2e-05	0.0008	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CA5A—glaucoma	9.03e-05	0.000784	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NARFL—glaucoma	9.03e-05	0.000784	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	8.81e-05	0.000765	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	8.63e-05	0.00075	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HEYL—glaucoma	8.56e-05	0.000744	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TXN—glaucoma	8.53e-05	0.000742	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CA5A—glaucoma	8.51e-05	0.000739	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NARFL—glaucoma	8.51e-05	0.000739	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTGFR—glaucoma	8.29e-05	0.000721	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDKN2A—glaucoma	8.16e-05	0.000709	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CA1—glaucoma	8.08e-05	0.000702	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	7.95e-05	0.000691	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—GSTT1—glaucoma	7.94e-05	0.00069	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	7.9e-05	0.000687	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	7.84e-05	0.000681	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CTSA—glaucoma	7.83e-05	0.00068	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—GSTM1—glaucoma	7.73e-05	0.000672	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HDAC9—glaucoma	7.63e-05	0.000663	CbGpPWpGaD
Temsirolimus—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	7.62e-05	0.000663	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SMO—glaucoma	7.43e-05	0.000646	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CA2—glaucoma	7.39e-05	0.000642	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.39e-05	0.000642	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CDKN2B—glaucoma	7.29e-05	0.000634	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDKN1B—glaucoma	7.22e-05	0.000628	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—glaucoma	7.1e-05	0.000617	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NTRK2—glaucoma	6.8e-05	0.000591	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—VEGFA—glaucoma	6.79e-05	0.00059	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—CDKN1B—glaucoma	6.77e-05	0.000589	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	6.76e-05	0.000588	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RPTOR—glaucoma	6.49e-05	0.000564	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—C3—glaucoma	6.4e-05	0.000556	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—CYP1B1—glaucoma	6.32e-05	0.000549	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NCK2—glaucoma	6.28e-05	0.000546	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.24e-05	0.000542	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—C3—glaucoma	6.14e-05	0.000534	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—BCL2L1—glaucoma	6.12e-05	0.000532	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MTHFR—glaucoma	6.11e-05	0.000531	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—VEGFA—glaucoma	6.01e-05	0.000522	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CA1—glaucoma	5.84e-05	0.000508	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NGFR—glaucoma	5.83e-05	0.000507	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—glaucoma	5.82e-05	0.000506	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	5.78e-05	0.000503	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—APOE—glaucoma	5.69e-05	0.000495	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CTSA—glaucoma	5.66e-05	0.000492	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CAV1—glaucoma	5.64e-05	0.00049	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CA5A—glaucoma	5.56e-05	0.000483	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NARFL—glaucoma	5.56e-05	0.000483	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—BAD—glaucoma	5.55e-05	0.000482	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NTRK1—glaucoma	5.54e-05	0.000482	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.41e-05	0.00047	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HDAC9—glaucoma	5.34e-05	0.000464	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CA2—glaucoma	5.34e-05	0.000464	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—BAD—glaucoma	5.33e-05	0.000463	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—BAD—glaucoma	5.3e-05	0.000461	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—TXN—glaucoma	5.21e-05	0.000453	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CDKN2B—glaucoma	5.11e-05	0.000444	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—GSTM1—glaucoma	5.05e-05	0.000439	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.98e-05	0.000433	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EDN1—glaucoma	4.9e-05	0.000426	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—TP53—glaucoma	4.54e-05	0.000394	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NGF—glaucoma	4.5e-05	0.000391	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CA1—glaucoma	4.41e-05	0.000383	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—C3—glaucoma	4.28e-05	0.000372	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CTSA—glaucoma	4.27e-05	0.000371	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NOS3—glaucoma	4.26e-05	0.000371	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.25e-05	0.00037	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1A—glaucoma	4.24e-05	0.000368	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SMO—glaucoma	4.18e-05	0.000363	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CA1—glaucoma	4.15e-05	0.000361	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CDKN2B—glaucoma	4.1e-05	0.000357	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTT1—glaucoma	4.04e-05	0.000351	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CA2—glaucoma	4.03e-05	0.00035	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.03e-05	0.00035	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CTSA—glaucoma	4.02e-05	0.00035	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—APOE—glaucoma	3.99e-05	0.000346	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CAV1—glaucoma	3.95e-05	0.000343	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTGS2—glaucoma	3.9e-05	0.000339	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CDKN1B—glaucoma	3.86e-05	0.000336	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NTRK2—glaucoma	3.82e-05	0.000332	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CA2—glaucoma	3.8e-05	0.00033	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—TXN—glaucoma	3.76e-05	0.000327	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FN1—glaucoma	3.76e-05	0.000327	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—C3—glaucoma	3.72e-05	0.000324	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—BAD—glaucoma	3.71e-05	0.000323	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CDKN1B—glaucoma	3.71e-05	0.000322	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CDKN1B—glaucoma	3.69e-05	0.000321	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—BCL2L1—glaucoma	3.57e-05	0.00031	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MTHFR—glaucoma	3.44e-05	0.000299	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.35e-05	0.000291	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NGFR—glaucoma	3.28e-05	0.000285	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—BAD—glaucoma	3.23e-05	0.000281	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ABCA1—glaucoma	3.22e-05	0.00028	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP1B1—glaucoma	3.22e-05	0.00028	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APOE—glaucoma	3.2e-05	0.000278	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CAV1—glaucoma	3.17e-05	0.000276	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NTRK1—glaucoma	3.12e-05	0.000271	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NOS3—glaucoma	2.99e-05	0.00026	CbGpPWpGaD
Temsirolimus—MTOR—Disease—BAD—glaucoma	2.98e-05	0.000259	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTT1—glaucoma	2.92e-05	0.000254	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDKN2B—glaucoma	2.87e-05	0.00025	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.87e-05	0.00025	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TXN—glaucoma	2.84e-05	0.000247	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EDN1—glaucoma	2.76e-05	0.00024	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CA1—glaucoma	2.72e-05	0.000236	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TXN—glaucoma	2.68e-05	0.000233	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CTSA—glaucoma	2.63e-05	0.000229	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CDKN1B—glaucoma	2.59e-05	0.000225	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTM1—glaucoma	2.57e-05	0.000224	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NGF—glaucoma	2.53e-05	0.00022	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.53e-05	0.00022	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CA2—glaucoma	2.48e-05	0.000216	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—C3—glaucoma	2.41e-05	0.000209	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS3—glaucoma	2.4e-05	0.000208	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—glaucoma	2.4e-05	0.000208	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ABCA1—glaucoma	2.33e-05	0.000202	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP1B1—glaucoma	2.33e-05	0.000202	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MTHFR—glaucoma	2.27e-05	0.000198	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDKN1B—glaucoma	2.25e-05	0.000196	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOE—glaucoma	2.24e-05	0.000195	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CAV1—glaucoma	2.22e-05	0.000193	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTT1—glaucoma	2.2e-05	0.000191	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—glaucoma	2.19e-05	0.000191	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—glaucoma	2.15e-05	0.000187	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOE—glaucoma	2.12e-05	0.000184	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FN1—glaucoma	2.11e-05	0.000184	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CAV1—glaucoma	2.1e-05	0.000182	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—BAD—glaucoma	2.09e-05	0.000182	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CDKN1B—glaucoma	2.08e-05	0.000181	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTT1—glaucoma	2.08e-05	0.00018	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTM1—glaucoma	1.86e-05	0.000162	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP1B1—glaucoma	1.75e-05	0.000153	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ABCA1—glaucoma	1.75e-05	0.000153	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TXN—glaucoma	1.75e-05	0.000152	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOS3—glaucoma	1.68e-05	0.000146	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ABCA1—glaucoma	1.65e-05	0.000144	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP1B1—glaucoma	1.65e-05	0.000144	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MTHFR—glaucoma	1.64e-05	0.000143	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—glaucoma	1.63e-05	0.000141	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—NOS3—glaucoma	1.59e-05	0.000138	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOE—glaucoma	1.53e-05	0.000133	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CAV1—glaucoma	1.52e-05	0.000132	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDKN1B—glaucoma	1.45e-05	0.000126	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—glaucoma	1.45e-05	0.000126	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTM1—glaucoma	1.4e-05	0.000122	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTT1—glaucoma	1.36e-05	0.000118	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—glaucoma	1.35e-05	0.000117	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTM1—glaucoma	1.32e-05	0.000115	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MTHFR—glaucoma	1.24e-05	0.000108	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—glaucoma	1.21e-05	0.000105	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MTHFR—glaucoma	1.17e-05	0.000102	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOE—glaucoma	1.15e-05	0.0001	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NOS3—glaucoma	1.15e-05	9.96e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CAV1—glaucoma	1.14e-05	9.94e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOE—glaucoma	1.09e-05	9.45e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP1B1—glaucoma	1.08e-05	9.4e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCA1—glaucoma	1.08e-05	9.4e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CAV1—glaucoma	1.08e-05	9.37e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—glaucoma	1.05e-05	9.11e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—glaucoma	9.14e-06	7.95e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NOS3—glaucoma	8.65e-06	7.52e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTM1—glaucoma	8.64e-06	7.51e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NOS3—glaucoma	8.15e-06	7.08e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—glaucoma	7.91e-06	6.87e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MTHFR—glaucoma	7.64e-06	6.64e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—glaucoma	7.45e-06	6.48e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOE—glaucoma	7.11e-06	6.18e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CAV1—glaucoma	7.05e-06	6.12e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NOS3—glaucoma	5.33e-06	4.63e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—glaucoma	4.87e-06	4.23e-05	CbGpPWpGaD
